Diabetic Eye Disease Detection by Primary-Care Physicians

Diabetes Care ◽  
1990 ◽  
Vol 13 (8) ◽  
pp. 908-909 ◽  
Author(s):  
S. B. Baker ◽  
C. Vallbona ◽  
J. V. Campbell ◽  
M. B. Hamill ◽  
B. Goetz ◽  
...  
Keyword(s):  
Primary Care ◽  
Primary Care Physicians ◽  
Eye Disease ◽  
Disease Detection ◽  
Diabetic Eye Disease

Prevalence of diabetic eye disease in patients entering a systematic primary care-based eye screening programme

2002 ◽  
Vol 19 (12) ◽  
pp. 1014-1021 ◽  
Author(s):  
N. Younis ◽  
D. M. Broadbent ◽  
S. P. Harding ◽  
J. P. Vora
Keyword(s):  
Primary Care ◽  
Screening Programme ◽  
Eye Disease ◽  
Eye Screening ◽  
Diabetic Eye Disease

scholarly journals The Indian Health Service Primary Care-Based Teleophthalmology Program for Diabetic Eye Disease Surveillance and Management

2020 ◽  
Vol 26 (12) ◽  
pp. 1466-1474 ◽  
Author(s):  
Stephanie J. Fonda ◽  
Sven-Erik Bursell ◽  
Drew G. Lewis ◽  
Dawn Clary ◽  
Dara Shahon ◽  
...  
Keyword(s):  
Primary Care ◽  
Health Service ◽  
Disease Surveillance ◽  
Eye Disease ◽  
Indian Health Service ◽  
Indian Health ◽  
Diabetic Eye Disease

Diabetic Eye Disease: Advancements in Technology, Detection, and Access to Care

2020 ◽  
Vol 35 (6) ◽  
pp. 266-272
Author(s):  
Trevor Lyford ◽  
John Sheppard
Keyword(s):  
Access To Care ◽  
Primary Care Physicians ◽  
Treatment Options ◽  
Eye Disease ◽  
Original Research ◽  
Technological Evolution ◽  
Treatment Regimens ◽  
Treatment Information ◽  
Included Review ◽  
Diabetic Eye Disease

OBJECTIVE: To educate pharmacists on advancements in, detection of, and access to care for diabetic eye disease (DED) by reviewing the etiologies, treatment options, and technological evolution in teleophthalmology for DED.<br/> DATA SYNTHESIS: The literature included review articles, original research articles, treatment information, and advancements in teleophthalmology for DED.<br/> CONCLUSION: DED encompasses a group of eye conditions that affect people with diabetes, which primarily includes diabetic retinopathy and diabetic macular edema but may also include cataracts, ocular surface disease, and glaucoma. Emerging technologies with retinal imaging tools and artificial intelligence have increased access to care for diabetic people with diabetes in many studies. Pharmacists familiar with diabetic screening advancements can work closely with primary care physicians and ophthalmologists to better educate patients on treatment regimens.

Evaluation and Referral of Diabetic Eye Disease in the Endocrinology and Primary Care Office Settings

2016 ◽  
Vol 47 (10) ◽  
pp. 930-934 ◽  
Author(s):  
Fabiana Q. Silva ◽  
Mehreen Adhi ◽  
Karen M. Wai ◽  
Leann Olansky ◽  
M. Cecilia Lansang ◽  
...  
Keyword(s):  
Primary Care ◽  
Eye Disease ◽  
Diabetic Eye Disease ◽  
Primary Care Office

Diabetic Eye Disease: Advancements in Technology, Detection, and Access to Care

2020 ◽  
Vol 35 (6) ◽  
pp. 266-272
Author(s):  
Trevor Lyford ◽  
John Sheppard
Keyword(s):  
Access To Care ◽  
Primary Care Physicians ◽  
Treatment Options ◽  
Eye Disease ◽  
Original Research ◽  
Technological Evolution ◽  
Treatment Regimens ◽  
Treatment Information ◽  
Included Review ◽  
Diabetic Eye Disease

OBJECTIVE: To educate pharmacists on advancements in, detection of, and access to care for diabetic eye disease (DED) by reviewing the etiologies, treatment options, and technological evolution in teleophthalmology for DED.<br/> DATA SYNTHESIS: The literature included review articles, original research articles, treatment information, and advancements in teleophthalmology for DED.<br/> CONCLUSION: DED encompasses a group of eye conditions that affect people with diabetes, which primarily includes diabetic retinopathy and diabetic macular edema but may also include cataracts, ocular surface disease, and glaucoma. Emerging technologies with retinal imaging tools and artificial intelligence have increased access to care for diabetic people with diabetes in many studies. Pharmacists familiar with diabetic screening advancements can work closely with primary care physicians and ophthalmologists to better educate patients on treatment regimens.

Diabetic Eye Disease: A Primary Care Perspective

1996 ◽  
Vol 89 (5) ◽  
pp. 463-470 ◽  
Author(s):  
KENNETH J. FRANK ◽  
J PAUL DIECKERT
Keyword(s):  
Primary Care ◽  
Eye Disease ◽  
Diabetic Eye Disease

Fool’s Gold: Psychologists Using Disingenuous Reasoning to Mislead Legislatures into Granting Psychologists Prescriptive Authority

2003 ◽  
Vol 29 (4) ◽  
pp. 489-524
Author(s):  
Brent Pollitt
Keyword(s):  
Primary Care ◽  
Mental Illness ◽  
Nurse Practitioners ◽  
Primary Care Physicians ◽  
American Psychological Association ◽  
The United States ◽  
Psychotropic Medications ◽  
American Psychological ◽  
Training Requirements ◽  
Prescriptive Authority

Mental illness is a serious problem in the United States. Based on “current epidemiological estimates, at least one in five people has a diagnosable mental disorder during the course of a year.” Fortunately, many of these disorders respond positively to psychotropic medications. While psychiatrists write some of the prescriptions for psychotropic medications, primary care physicians write more of them. State legislatures, seeking to expand patient access to pharmacological treatment, granted physician assistants and nurse practitioners prescriptive authority for psychotropic medications. Over the past decade other groups have gained some form of prescriptive authority. Currently, psychologists comprise the primary group seeking prescriptive authority for psychotropic medications.The American Society for the Advancement of Pharmacotherapy (“ASAP”), a division of the American Psychological Association (“APA”), spearheads the drive for psychologists to gain prescriptive authority. The American Psychological Association offers five main reasons why legislatures should grant psychologists this privilege: 1) psychologists’ education and clinical training better qualify them to diagnose and treat mental illness in comparison with primary care physicians; 2) the Department of Defense Psychopharmacology Demonstration Project (“PDP”) demonstrated non-physician psychologists can prescribe psychotropic medications safely; 3) the recommended post-doctoral training requirements adequately prepare psychologists to prescribe safely psychotropic medications; 4) this privilege will increase availability of mental healthcare services, especially in rural areas; and 5) this privilege will result in an overall reduction in medical expenses, because patients will visit only one healthcare provider instead of two–one for psychotherapy and one for medication.

Sign in / Sign up

Export Citation Format

Share Document